|
|
|
|
|
by suryong
1403 days ago
|
|
What we really need is robust treatments that either slow down the ageing process or reverse it to some extent. There is some promising research relating to both slowing and reversing. The current approach where we treat age related disease as individual things will never really work out in the long term One thing right now that is available is rapamycin which basically improves health span and lifespan for every animal it is given, won't make you live to 150 but will probably reduce risk of disease. I am considering starting rapamycin myself as my mom was diagnosed with ALS few months ago (doesn't seem strictly genetic as her mom and dad lived relatively long and didn't get that disease), so I might have some risk genes.. World where people live to 90-100 and where increasing amount have dementia or other age related disease won't be a nice place |
|
Note every animal. Quoting https://link.springer.com/article/10.1007/s11357-020-00274-1:
] Although the overwhelming majority of studies on the effect of rapamycin on longevity in mice have shown a significant increase in lifespan, there are five studies that have reported either no effect or reduced lifespan when treated with rapamycin.
When you write "every animal it is given" .. do you mean only flies and mice?
I've been having a hard time finding results for any other animals.
There's a decade of research with marmosets (here's a 2012 mention about it in Nature - https://www.nature.com/articles/492S18a ), but none of the papers I find report lifespan, only secondary measures (eg, "Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets" - https://onlinelibrary.wiley.com/doi/10.1002/ajp.22927 ).
Since marmosets live for about 15 to 16 years, surely there should be something concrete by now if it has the same effect on middle-aged marmosets when the research started.
I found there's research for dogs, but https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507265/ says it's also ongoing. I haven't found any published results on lifespan only, again, on secondary effects (eg, quoting the paper, "An initial randomized, double-blind veterinary clinical trial confirmed the safety of this treatment and provided indications of potential efficacy (benefits for cardiac function) in dogs".)
What other animals have shown improved lifespan with rapamycin?
If it's only flies and (most) mice, is that really enough to call it "promising" in humans?